procter & gamble

10
Procter & Gamble v/s Colgate – 2003 An Exercise in Competitive Dynamics (From Colgate’s perspective) Presented By: Group A08

Upload: laghima-gupta

Post on 20-Nov-2015

64 views

Category:

Documents


7 download

DESCRIPTION

Procter & Gamble

TRANSCRIPT

  • Procter & Gamble v/s Colgate 2003

    An Exercise in Competitive Dynamics

    (From Colgates perspective) Presented By:

    Group A-08

  • Industry Future Projections

    Low entry barriers New entrants will be there P&G will resort to aggressive promotion Market will grow Natural Segmentation on the basis of price P&G might come up with a gel at a cheaper or similar price

    Characteristic Entry Barrier

    Minimal Customer switching costs Low

    High Capital Requirements High

    Increasing Demand Low

    Easy Distribution channel access Low

    Patented Products High

  • Target segment

    Our segment comprises price-sensitive people who are conscious about their teeth and dental hygiene.

    We target to provide value through our quality product offering at a relatively less price.

    The main competitor, P&G, is active in the premium segment.

    Their main competitor based on price is Rembrandt.

  • Competitor Both P&G Crest Whitestrips and Colgate Simply White Night target the

    urban consumers who are well aware of the oral care segment.

    The motivation for P&G consumers would be higher than that of Colgate consumers, as they would have to pay $44.

    Investment and Recovery by P&G:

    Initial Marketing $90 million

    Media Campaign $33.6 million

    Year 1 Net income 45% * $200 million $90 million

    Year 2 Net Income 45% * 40% * 300 million $54 million

  • Strategy

    Focus will be on Product Improvement No new product will be launched Focus on women and working professionals

    Arena

    Internal Developments R&D to improve products

    Vehicle

    Price Convenience

    Differentiator

  • Staging & Sequencing

    0 0.5 1 1.5 2 2.5 3 3.5

    Mass Retail

    Pharmacies

    Launch New & Promotions

    R&D - Stage 2

    Mass Retail

    Pharmacies

    Launch New & Promotions

    R&D - Stage 1

    Launch in Mass Retail Channel

    Pharmacies

    Promotions

    Years

  • Economic Logic

    2001 2002 2003 2004 2005 2006

    Market size 300.00 356.70 424.12 504.27 600.00

    Share 30% 33% 36% 40% 44%

    Sales 90.00 117.71 153.95 201.36 263.54

    Profit 40.50 52.97 69.28 90.61 118.59

    R&D cost (20.00) (9.00) (11.77) (15.40) (20.14) (26.35)

    Investment (R&D + marketing) (60.00) (40.00) (40.00) (40.00) (40.00)

    Net cash flow (20.00) (28.50) 1.20 13.88 30.47 52.24

    IRR 20.59%

    NPV (15% discount rate) 8.65

    * All figures are in million USD

  • Table 1

    We would continue with our own product, but would do R&D for the next few years.

    Our differentiators are low price and the dual use of the product packaging. It would continue.

    We have enough resources, since we are already the market leader. We would spend $10m in 2003, and would grow by 10% every year. The IRR is 20.5%.

  • Possible Threats

    P&G poses a threat to us. They might come up with a gel and price it at around $15.

    Competitors have started coming up with products with intellectual property protected ingredients. This would increase the entry barriers.

    Buyers would have less power as most products have different offerings.

  • Thank you.